Study of Ascending Levels of Tolvaptan in Hyponatremia

Record History

1. Minor Jul 10, 2026 Primary completion date: Jul 1, 2005 Completion date: Jul 2005 to Jul 1, 2005 · Start date: Nov 2003 to Nov 1, 2003 · Interventions: Tolvaptan (Drug) to Placebo (Drug), Tolvaptan (Drug) · 4 morev8 Show all 8 changesShow less

   • Completion date: Jul 2005 to Jul 1, 2005
   • Start date: Nov 2003 to Nov 1, 2003
   • Interventions: Tolvaptan (Drug) to Placebo (Drug), Tolvaptan (Drug)
   • Eligibility criteria expanded, about 8 words
   • Study arms: 0 to 2
   • Study description shortened, about 4 words
   • Study title shortened, about 2 words

   See this version in full on ClinicalTrials.gov ↗

2. Minor May 2, 2012 2 versions Re-verified since Sep 2, 2008, no change to tracked fieldsv6-v7
3. Minor Mar 25, 2008 Trial status: Active, Not Recruiting to Completedv5
4. Minor Jan 24, 2007 Re-verified, no change to tracked fieldsv4
5. Notable Dec 27, 2006 Primary endpoints revised (3) Secondary endpoints revised (3)v3 Show all 2 changesShow less

   • Secondary endpoints revised (3)

   See this version in full on ClinicalTrials.gov ↗

6. Minor Dec 20, 2005 Eligibility criteria revisedv2 Show moreShow less

   See this version in full on ClinicalTrials.gov ↗

7. Minor Sep 14, 2005 Study First Submitted

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.